Review
NOVOS Core Review: Ingredients, Cost and the Human Evidence
NOVOS Core has a published human vascular trial, but no proven lifespan benefit. Review its current formula, $109 single-box price and subscription terms.
On this page
Featured partner
Grade B
CoreAge Rx
Clinician-reviewed NAD+ and sermorelin with published starting prices and human support. Confirm the full cost and renewal terms before paying.
$93–$99/mo (starting rates)
We may earn a commission through this link, at no extra cost to you.
Check availability- Pricing
- Varies by plan
- Pharmacy
- 503A compounding pharmacy
- Labs
- Depends on treatment
- Consult
- Clinician review included
- Support
- Human support included
Grades come from each provider's published terms. How we're funded
Partner
Grade B
Gala Health
A new NAD+ and sermorelin line at $199 a month with the visit and shipping included — from a GLP-1 brand that names no pharmacy.
$199/mo NAD+ or sermorelin
We may earn a commission through this link, at no extra cost to you.
Visit Gala Health$199 "a month" buys a 28-day supply, and the page does not say whether refills are billed monthly or every 28 days (13 charges a year rather than 12). Compounded and not FDA-approved. Graded on the same rubric as every other provider on our scorecard.
Our assessment
NOVOS Core has preliminary human evidence for vascular function, but has not been shown to extend human life. Its six-month STAMINA trial tested the finished formula against placebo. The company's clinical research summary reports favorable vascular measurements, alongside important limits.6 Our STAMINA evidence analysis explains the published results and what they mean for a buyer.
This review evaluates published research, the current product label and purchase terms; it is not a firsthand product test. Core may appeal to someone who values a daily multi-ingredient drink and accepts uncertain long-term benefits. At $109 for one box or $98 on a monthly subscription, the financial commitment deserves as much attention as the science.1 Our broader longevity evidence guide explains how biomarkers differ from health outcomes.
What Core costs
Prices below are the publicly advertised US dollar offers checked October 15, 2026, before any applicable tax or checkout charges. Each box contains 30 sachets: 30 days at one sachet daily, rather than a guaranteed calendar month. The six- and twelve-box offers require the full payment upfront.29
Core pricing · October 2026
| Plan | Paid upfront | Supply | Per 30 servings |
|---|---|---|---|
| One-time | $109 | 1 box · 30 days | $109 |
| Monthly subscription | $98 | 1 box · 30 days | $98 |
| Six-month subscription | $559 | 6 boxes · 180 days | $93.17 |
| Annual subscription | $950 | 12 boxes · 360 days | $79.17 |
The advertised $93 and $79 per-box figures are rounded: $559 ÷ 6 is $93.17; $950 ÷ 12 is $79.17. Twelve boxes provide 360 servings. Subscriptions renew automatically until canceled, so the annual price is a recurring $950 commitment at the listed rate, not a $79 monthly payment.23
Cancellation and refunds: the current policy requires pausing or canceling at least one business day before renewal. US returns must be unopened and within 30 days; a refund to the original payment method deducts $25 for shipping and $35 for restocking per transaction. Choosing store credit waives those $60 fees, but the credit expires after one year. International orders are final. This is not an opened-product satisfaction guarantee.4 The product page promises free subscription shipping; confirm the final shipping and tax treatment for your destination.1
Core and Boost are different products
Core is a daily powder sold in Orange, Tropical Passion and Unflavored versions. The product page's current Supplement Facts uses a 15 g serving. Flavor ingredients can differ, so check the package for the variant you receive.1
Boost is a separate NMN capsule product, not an ingredient included in Core. A bottle contains 60 capsules; two supply 250 mg NMN, giving 30 days at that dose or 15 days at four capsules daily. Its listed single-bottle price is $44 and monthly subscription is $39.50, additional to Core. Boost's cited human NMN research used other study products; it should not be presented as a clinical trial of Boost itself.5 The STAMINA findings below concern Core, while the small epigenetic pilot used Core plus Boost.
The current Core formula
The current online label lists these amounts per serving. Magnesium and malate are disclosed separately even though both come from magnesium malate; calcium is supplied by calcium alpha-ketoglutarate. Do not count them as extra independent doses.1
- Glycine: 2,000 mg.
- Malate: 1,700 mg; magnesium: 304 mg, as magnesium malate.
- Calcium alpha-ketoglutarate: 1,100 mg, supplying 231 mg calcium.
- Vegan glucosamine sulfate: 1,000 mg.
- Rhodiola rosea root extract: 300 mg, standardized to 3% rosavins and 1% salidrosides.
- L-theanine: 150 mg.
- Hyaluronic acid, fisetin and vitamin C: 100 mg each.
- Organic ginger root extract: 100 mg, standardized to 2% gingerols.
- Pterostilbene: 50 mg.
- Lithium aspartate: 20 mg, providing 1 mg elemental lithium.
Those last two lithium quantities are not interchangeable: this is not 20 mg of elemental lithium. A disclosed dose makes the formula easier to assess; it does not establish that each ingredient contributes to a benefit or that every dose is optimal.
How strong is the evidence?
The company's clinical hub describes a randomized, double-blind trial of Core in adults over 40. Sixty-one were randomized and 43 had complete six-month measurements. The reported benefits concern blood-vessel function and blood pressure; the study did not demonstrate longer life or fewer heart attacks.6 Read our analysis of the Core clinical trial for publication status, the size of the changes, funding and follow-up limitations.
What the evidence supports
- BHuman vascular markersModerate evidence
One small randomized finished-formula trial, published as an accepted manuscript; incomplete follow-up limits certainty.
- CSkin firmness and epigenetic pilotsWeak evidence
Small uncontrolled observations; the epigenetic pilot combined Core with Boost.
- CAnimal and cell findingsWeak evidence
Laboratory and animal findings help frame research questions; they cannot establish human lifespan benefit.
- DLonger human lifeInsufficient
No demonstrated reduction in mortality or extension of human lifespan.
NOVOS also reports small uncontrolled skin and epigenetic pilots. The epigenetic pilot combined Core with Boost, so its findings cannot establish what Core alone does.7 Our biological-age testing guide explains why a clock score needs cautious interpretation.
A formula also cannot inherit every finding from research on its individual ingredients. Our guides discuss GlyNAC, fisetin, alpha-ketoglutarate, microdose lithium and resveratrol-related longevity claims.
Safety and who should be cautious
Core is a dietary supplement. FDA does not approve dietary supplements for safety and effectiveness before sale; publication of a study is not FDA approval of an anti-aging treatment.8
Have a clinician or pharmacist review the full formula alongside your medicines and other supplements before using it. NOVOS advises professional guidance for people with medical conditions or prescriptions, particularly during pregnancy or nursing and when managing blood pressure, bleeding or clotting. The six-month research does not settle suitability for every person or establish safety for decades of daily use.2
Is NOVOS Core worth buying?
The strongest reason to consider Core is convenience combined with preliminary randomized evidence on vascular function. The strongest reasons to hesitate are cost, a fixed blend you cannot adjust ingredient by ingredient, and uncertainty about meaningful long-term health benefits. The annual discount reduces the serving cost while increasing the amount prepaid.
Our assessment is promising but preliminary for vascular markers; unproven for extending human lifespan. A consumer seeking an established anti-aging outcome should not read the vascular study, mouse survival result or biological-age pilot as that proof.
Core is also a different purchase from clinician-supervised care. Our longevity clinic rankings compare programs and memberships, while the supplement guide covers this category. For the comparison with a testing-focused brand, see NOVOS vs Tally Health.
Providers to compare
We may earn a commission through these links, at no extra cost to you. Disclosure
Luvo Health
$199 per 4 weeks NAD+ or sermorelinEverPrime
$180/mo standard medicationStrut Health
$99–$119/moFDA warning letter · February 2026
Partner
Bodybuilding Health+ From $129/mo (term not stated)
Frequently asked questions
Does NOVOS Core have a human clinical trial?
Yes. The company reports a randomized, placebo-controlled Core trial with favorable six-month vascular measurements. It did not establish longer life or fewer cardiovascular events. Our linked trial analysis explains the publication, results and limitations.
How much does NOVOS Core cost?
The October 15, 2026 advertised US prices are $109 once, $98 for the monthly subscription, $559 prepaid for six boxes or $950 prepaid for twelve. Each box supplies 30 daily servings. Subscriptions automatically renew; applicable tax and checkout charges may add to the total.
Does Core include NMN?
No. NMN is sold separately as NOVOS Boost. Its two-capsule serving contains 250 mg NMN. The Core vascular trial and the Core-plus-Boost epigenetic pilot studied different interventions.
Can I try Core and return it if I feel no difference?
The published policy does not offer an opened-product satisfaction guarantee. US returns must be unopened and within 30 days, with $60 in shipping and restocking deductions for a refund. Store credit waives those fees and expires after a year. International purchases are final.
References
- NOVOS (2026). NOVOS Core — product information and Supplement Facts (accessed October 15, 2026). NOVOS.
- NOVOS (2026). NOVOS Core — plan totals and serving information (accessed October 15, 2026). NOVOS.
- NOVOS (2026). Terms and Conditions — automatic renewals and prepaid subscriptions (accessed October 15, 2026). NOVOS.
- NOVOS (2026). Return policy — cancellation, refunds and international orders (accessed October 15, 2026). NOVOS.
- NOVOS (2026). NOVOS Boost — dose, bottle size, prices and research attribution (accessed October 15, 2026). NOVOS.
- NOVOS (2026). Clinical studies hub — STAMINA design, attrition and funding (accessed October 15, 2026). NOVOS.
- NOVOS (2026). Scientific evidence behind NOVOS — epigenetic and skin pilots (accessed October 15, 2026). NOVOS.
- U.S. Food and Drug Administration (2026). Questions and Answers on Dietary Supplements. FDA.
- NOVOS (2026). Core packaging and 30-day supply (accessed October 15, 2026). NOVOS.
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
More graded reviews
Rapamycin for Longevity: Hype vs Evidence
Rapamycin is the most reproducible lifespan extender in mice — but there is no human longevity trial. An honest split of the hype from the evidence.
ReadGLP-1s for Healthspan & Longevity: The Evidence
GLP-1 drugs have the strongest human outcome data in longevity — but it's cardiometabolic risk reduction, not proven lifespan extension. An honest review.
ReadDoes Resveratrol Actually Work for Longevity?
A skeptical, evidence-graded review: the SIRT1 story was an artifact, a 2025 primate trial found no lifespan benefit, and oral resveratrol barely reaches cells.
ReadNOVOS Core Clinical Trial: What STAMINA Actually Shows
STAMINA found favorable vascular markers after six months of NOVOS Core. Examine the published trial, incomplete follow-up and limits of its longevity claims.
ReadLongevity Medicine: What's Proven vs Hyped
An honest, evidence-graded tour of the longevity toolkit — what has human outcome RCTs versus what is animal or mechanistic-only.
ReadDo NAD+ and Peptides Actually Extend Lifespan?
NAD+ precursors reliably raise NAD+ but show modest, mixed human outcomes. Peptides and growth hormone carry real cautions. An honest evidence review.
Read